Different affective response to opioid withdrawal in adolescent and adult mice

Life Sciences

Volumn 84, Issue 1-2, 2009, Pages 52-60

  Hodgson, Stephen R ^a   Hofford, Rebecca S ^a   Wellman, Paul J ^a   Eitan, Shoshana ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Age related differences; Dependence; Drug addiction; Forced swim test (FST); Locomotion; Morphine

Indexed keywords

MORPHINE; OPIATE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; IMMOBILIZATION; LOCOMOTION; MALE; MENTAL DISEASE; MOOD DISORDER; MOTOR ACTIVITY; MOUSE; NONHUMAN; OPIATE ADDICTION; RISK ASSESSMENT;

AGE FACTORS; ANIMALS; MALE; MICE; MICE, INBRED C57BL; MORPHINE; MORPHINE DEPENDENCE; MOTOR ACTIVITY; RECEPTORS, OPIOID; SUBSTANCE WITHDRAWAL SYNDROME; SWIMMING;

ANIMALIA; MUS; RODENTIA;

EID: 57649238600     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.11.002     Document Type: Article

References (83)

1. Abreu-Villaça Y., Medeiros A.H., Lima C.S., Faria F.P., Filgueiras C.C., and Manhães A.C. Combined exposure to nicotine and ethanol in adolescent mice differentially affects memory and learning during exposure and withdrawal. Behavioural Brain Research 181 1 (2007) 136-146
2. Anraku T., Ikegaya Y., Matsuki N., and Nishiyama N. Withdrawal from chronic morphine administration causes prolonged enhancement of immobility in rat forced swimming test. Psychopharmacology (Berlin) 157 2 (2001) 217-220
3. Baamonde A., Daugé V., Ruiz-Gayo M., Fulga I.G., Turcaud S., Fournié-Zaluski M.C., and Roques B.P. Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid delta and dopamine D1 receptor stimulation. The European Journal of Pharmacology 216 2 (1992) 157-166
4. Berrendero F., Kieffer B.L., and Maldonado R. Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice. The Journal of Neuroscience 22 24 (2002) 10935-10940
5. Bolanos C.A., Garmsen G.M., Clair M.A., and McDougall S.A. Effects of the kappa-opioid receptor agonist U-50,488 on morphine-induced place preference conditioning in the developing rat. European Journal of Pharmacology 317 1 (1996) 1-8
6. Budney A.J., Novy P., and Hughes J.R. Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction 94 9 (1999) 1311-1322
7. Byrnes E.M. Chronic morphine exposure during puberty induces long-lasting changes in opioid-related mRNA expression in the mediobasal hypothalamus. Brain Research 1190 (2008) 186-192
8. Campbell J.O., Wood R.D., and Spear L.P. Cocaine and morphine-induced place conditioning in adolescent and adult rats. Physiology and Behavior 68 4 (2000) 487-493
9. Carlezon Jr. W.A., Béguin C., DiNieri J.A., Baumann M.H., Richards M.R., Todtenkopf M.S., Rothman R.B., Ma Z., Lee D.Y., and Cohen B.M. Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. The Journal of Pharmacology and Experimental Therapeutics 316 1 (2006) 440-447
10. Carretero J., Bodego P., Rodriguez R.E., Rubio M., Blanco E., and Burks D.J. Expression of the mu-opioid receptor in the anterior pituitary gland is influenced by age and sex. Neuropeptides 38 2-3 (2004) 63-68
11. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H., Taylor A., Arseneault L., Williams B., Braithwaite A., Poulton R., and Craig I.W. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biological Psychiatry 57 10 (2005) 1117-1127
12. Contet C., Filliol D., Matifas A., and Kieffer B.L. Morphine-induced analgesic tolerance, locomotor sensitization and physical dependence do not require modification of micro opioid receptor, cdk5 and adenylate cyclase activity. Neuropharmacology 54 3 (2008) 475-486
13. Corrigall W.A., Coen K.M., Adamson K.L., Chow B.L., and Zhang J. Response of nicotine self-administration in the rat to manipulations of mu-opioid and gamma-aminobutyric acid receptors in the ventral tegmental area. Psychopharmacology (Berlin) 149 2 (2000) 107-114
14. Crowley J.J., Jones M.D., O'Leary O.F., and Lucki I. Automated tests for measuring the effects of antidepressants in mice. Pharmacology, Biochemistry, and Behavior 78 2 (2004) 269-274
15. Cryan J.F., Valentino R.J., and Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neuroscience and Biobehavioral Reviews 29 4-5 (2005) 547-569
16. Degenhardt L., Coffey C., Moran P., Carlin J.B., and Patton G.C. The predictors and consequences of adolescent amphetamine use: findings from the Victoria Adolescent Health Cohort Study. Addiction 102 7 (2007) 1076-1084
17. Diaz S.L., Hermida M.P., Joannas L.D., Olivera M., Ridolfi A., Villaamil E.C., and Balerio G.N. Pharmacokinetic aspects of naloxone-precipitated morphine withdrawal in male and female prepubertal mice. Biopharmaceutics and Drug Disposition 28 6 (2007) 283-289
18. Doremus-Fitzwater T.L., and Spear L.P. Developmental differences in acute ethanol withdrawal in adolescent and adult rats. Alcoholism, Clinical and Experimental Research 31 9 (2007) 1516-1527
19. Eitan S., Bryant C.D., Saliminejad N., Yang Y.C., Vojdani E., Keith Jr. D., Polakiewicz R., and Evans C.J. Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization. Journal of Neuroscience 23 23 (2003) 8360-8369 (2003)
20. el-Kadi A.O., and Sharif S.I. The influence of various experimental conditions on the expression of naloxone-induced withdrawal symptoms in mice. General Pharmacology 25 7 (1994) 1505-1510
21. Fukunaga Y., Nishida S., Inoue N., Miyamoto M., Kishioka S., and Yamamoto H. Time course of morphine withdrawal and preproenkephalin gene expression in the periaqueductal gray of rats. Brain Research. Molecular Brain Research 55 2 (1998) 221-231
22. Gazyakan E., Disko U., Haaf A., Heimrich B., and Jackisch R. Postnatal development of opioid receptors modulating acetylcholine release in hippocampus and septum of the rat. Brain Research. Developmental Brain Research 123 2 (2000) 135-141
23. Gfroerer J.C., Wu L.T., and Penne M.A. Initiation of Marijuana Use: Trends, Patterns, and Implications (DHHS Publication No. SMA 02-3711, Analytic Series A-17) (2002), Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Rockville, MD
24. Ghozland S., Chu K., Kieffer B.L., and Roberts A.J. Lack of stimulant and anxiolytic-like effects of ethanol and accelerated development of ethanol dependence in mu-opioid receptor knockout mice. Neuropharmacology 49 4 (2005) 493-501
25. Grasing K., and Ghosh S. Selegiline prevents long-term changes in dopamine efflux and stress immobility during the second and third weeks of abstinence following opiate withdrawal. Neuropharmacology 37 8 (1998) 1007-1017
26. Hall F.S., Sora I., and Uhl G.R. Ethanol consumption and reward are decreased in mu-opiate receptor knockout mice. Psychopharmacology (Berlin) 154 1 (2001) 43-49
27. Hand T.H., Koob G.F., Stinus L., and Le Moal M. Aversive properties of opiate receptor blockade: evidence for exclusively central mediation in naive and morphine-dependent rats. Brain Research 474 2 (1988) 364-368
28. Handal M., Grung M., Skurtveit S., Ripel A., and Mørland J. Pharmacokinetic differences of morphine and morphine-glucuronides are reflected in locomotor activity. Pharmacology, Biochemistry, and Behavior 73 4 (2002) 883-892
29. Handelsman L., Aronson M.J., Ness R., Cochrane K.J., and Kanof P.D. The dysphoria of heroin addiction. The American Journal of Drug and Alcohol Abuse 18 3 (1992) 275-287
30. Ingram S.L., Fossum E.N., and Morgan M.M. Behavioral and electrophysiological evidence for opioid tolerance in adolescent rats. Neuropsychopharmacology 32 3 (2007) 600-606
31. Jacobson L.H., and Cryan J.F. Feeling strained? Influence of genetic background on depression-related behavior in mice: a review. Behavior Genetics 37 1 (2007) 171-213
32. Janiri L., Martinotti G., Dario T., Reina D., Paparello F., Pozzi G., Addolorato G., Di Giannantonio M., and De Risio S. Anhedonia and substance-related symptoms in detoxified substance-dependent subjects: a correlation study. Neuropsychobiology 52 1 (2005) 37-44
33. Jutkiewicz E.M., Rice K.C., Woods J.H., and Winsauer P.J. Effects of the delta-opioid receptor agonist SNC80 on learning relative to its antidepressant-like effects in rats. Behavioural Pharmacology 14 7 (2003) 509-516
34. Kest B., Palmese C.A., Hopkins E., Adler M., and Juni A. Assessment of acute and chronic morphine dependence in male and female mice. Pharmacology, Biochemistry, and Behavior 70 1 (2001) 149-156
35. Kirk R.E. Experimental Design: Procedures for the Behavioral Sciences. Second ed. (1982), Wadsworth, Belmont California 83
36. Kivell B.M., Day D.J., McDonald F.J., and Miller J.H. Developmental expression of mu and delta opioid receptors in the rat brainstem: evidence for a postnatal switch in mu isoform expression. Brain research. Developmental Brain Research 148 2 (2004) 185-196
37. Kota D., Martin B.R., Robinson S.E., and Damaj M.I. Nicotine dependence and reward differ between adolescent and adult male mice. The Journal of Pharmacology and Experimental Therapeutics 322 1 (2007) 399-407
38. Kovacs K.M., Szakall I., O'Brien D., Wang R., Vinod K.Y., Saito M., Simonin F., Kieffer B.L., and Vadasz C. Decreased oral self-administration of alcohol in kappa-opioid receptor knock-out mice. Alcoholism, Clinical and Experimental Research 29 5 (2005) 730-738
39. Mague S.D., Pliakas A.M., Todtenkopf M.S., Tomasiewicz H.C., Zhang Y., Stevens Jr. W.C., Jones R.M., Portoghese P.S., and Carlezon Jr. W.A. Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. The Journal of Pharmacology and Experimental Therapeutics 305 1 (2003) 323-330
40. Maremmani I., Perugi G., Pacini M., and Akiskal H.S. Toward a unitary perspective on the bipolar spectrum and substance abuse: opiate addiction as a paradigm. Journal of Affective Disorders 93 1-3 (2006) 1-12
41. Mathers M., Toumbourou J.W., Catalano R.F., Williams J., and Patton G.C. Consequences of youth tobacco use: a review of prospective behavioural studies. Addiction 101 7 (2006) 948-958
42. Matthes H.W., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dolle P., Tzavara E., Hanoune J., Roques B.P., and Kieffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383 6603 (1996) 819-823
43. Molina V.A., Heyser C.J., and Spear L.P. Chronic variable stress or chronic morphine facilitates immobility in a forced swim test: reversal by naloxone. Psychopharmacology (Berlin) 114 3 (1994) 433-440
44. Narita M., Kuzumaki N., Narita M., Kaneko C., Tamai E., Khotib J., Miyatake M., Shindo K., Nagumo Y., Tanaka S., and Suzuki T. Age-related emotionality is associated with cortical delta-opioid receptor dysfunction-dependent astrogliosis. Neuroscience 137 4 (2006) 1359-1367
45. National Survey. Results from the 2005 National Survey on Drug Use & Health: National Findings (2006), Office of Applied Studies, Substance Abuse & Mental Health Services Administration (SAMHSA), US department of Health and Human Services, Rockville, Maryland, USA
46. Nieto M.M., Guen S.L., Kieffer B.L., Roques B.P., and Noble F. Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptors. Neuroscience 135 2 (2005) 305-313
47. Nozaki M., Akera T., Lee C.Y., and Brody T.M. The effects of age on the development of tolerance to and physical dependence on morphine in rats. The Journal of Pharmacology and Experimental Therapeutics 192 3 (1975) 506-512
48. Nylander I., Vlaskovska M., and Terenius L. Brain dynorphin and enkephalin systems in Fischer and Lewis rats: effects of morphine tolerance and withdrawal. Brain Research 683 1 (1995) 25-35
49. Nylander I., Vlaskovska M., and Terenius L. The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley rats. Psychopharmacology (Berlin) 118 4 (1995) 391-400
50. O'Dell L.E., Bruijnzeel A.W., Smith R.T., Parsons L.H., Merves M.L., Goldberger B.A., Richardson H.N., Koob G.F., and Markou A. Diminished nicotine withdrawal in adolescent rats: implications for vulnerability to addiction. Psychopharmacology (Berlin) 186 4 (2006) 612-619
51. O'Dell L.E., Torres O.V., Natividad L.A., and Tejeda H.A. Adolescent nicotine exposure produces less affective measures of withdrawal relative to adult nicotine exposure in male rats. Neurotoxicology and Teratology 29 1 (2007) 17-22
52. Perona M.T., Waters S., Hall F.S., Sora I., Lesch K.P., Murphy D.L., Caron M., and Uhl G.R. Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions. Behavioural Pharmacology 19 5-6 (2008) 566-574
53. Perrine S.A., Sheikh I.S., Nwaneshiudu C.A., Schroeder J.A., and Unterwald E.M. Withdrawal from chronic administration of cocaine decreases delta opioid receptor signaling and increases anxiety- and depression-like behaviors in the rat. Neuropharmacology 54 2 (2008) 355-364
54. Porsolt R.D., Bertin A., and Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Archives Internationales de Pharmacodynamie et de Thérapie 229 2 (1977) 327-336
55. Porsolt R.D., Brossard G., Hautbois C., and Roux S. Rodent models of depression: forced swimming and tail suspension behavioral despair tests in rats and mice. Current Protocols in Neuroscience Chapter 8, Unit 8.10A (2001)
56. Schaefer G.J., and Michael R.P. Morphine withdrawal produces differential effects on the rate of lever-pressing for brain self-stimulation in the hypothalamus and midbrain in rats. Pharmacology, Biochemistry, and Behavior 18 4 (1983) 571-577
57. Schulteis G., Markou A., Gold L.H., Stinus L., and Koob G.F. Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. The Journal of Pharmacology and Experimental Therapeutics 271 3 (1994) 1391-1398
58. Schürks M., Overlack M., and Bonnet U. Naltrexone treatment of combined alcohol and opioid dependence: deterioration of co-morbid major depression. Pharmacopsychiatry 38 2 (2005) 100-102
59. Shirayama Y., Ishida H., Iwata M., Hazama G.I., Kawahara R., and Duman R.S. Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. Journal of Neurochemistry 90 5 (2004) 1258-1268
60. Shobe F.O., and Brion P. Long-term prognosis in manic-depressive illness. Archives of General Psychiatry 24 4 (1971) 334-337
61. Smith A.E., Cavallo D.A., Dahl T., Wu R., George T.P., and Krishnan-Sarin S. Effects of acute tobacco abstinence in adolescent smokers compared with nonsmokers. The Journal of Adolescent Health 43 1 (2008) 46-54
62. Spanagel R., Almeida O.F., Bartl C., and Shippenberg T.S. Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release. Psychopharmacology (Berlin) 115 1-2 (1994) 121-127
63. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neuroscience and Biobehavioral Reviews 24 4 (2000) 417-463
64. Spear L.P., Horowitz G.P., and Lipovsky J. Altered behavioral responsivity to morphine during the periadolescent period in rats. Behavioural Brain Research 4 3 (1982) 279-288
65. Todtenkopf M.S., Marcus J.F., Portoghese P.S., and Carlezon Jr. W.A. Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats. Psychopharmacology (Berlin) 172 4 (2004) 463-470
66. Torregrossa M.M., Jutkiewicz E.M., Mosberg H.I., Balboni G., Watson S.J., and Woods J.H. Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test and regulate BDNF mRNA expression in rats. Brain Research 1069 1 (2006) 172-181
67. Tucker J.S., Ellickson P.L., Collins R.L., and Klein D.J. Does solitary substance use increase adolescents' risk for poor psychosocial and behavioral outcomes? A 9-year longitudinal study comparing solitary and social users. Psychology of Addictive Behaviors: Journal of the Society of Psychologists in Addictive Behaviors 20 4 (2006) 363-372
68. Ueno E., Liu D.D., Ho I.K., and Hoskins B. Opiate receptor characteristics in brains from young, mature and aged mice. Neurobiology of Aging 9 3 (1988) 279-283
69. Uhl G.R., Ryan J.P., and Schwartz J.P. Morphine alters preproenkephalin gene expression. Brain Research 459 2 (1988) 391-397
70. Van Bockstaele E.J., Peoples J., Menko A.S., McHugh K., and Drolet G. Decreases in endogenous opioid peptides in the rat medullo-coerulear pathway after chronic morphine treatment. The Journal of Neuroscience 20 23 (2000) 8659-8666
71. Vandrey R., Budney A.J., Kamon J.L., and Stanger C. Cannabis withdrawal in adolescent treatment seekers. Drug and Alcohol Dependence 78 2 (2005) 205-210
72. Vergura R., Balboni G., Spagnolo B., Gavioli E., Lambert D.G., McDonald J., Trapella C., Lazarus L.H., Regoli D., Guerrini R., Salvadori S., and Caló G. Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH(2)-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist. Peptides 29 1 (2008) 93-103
73. Walker B.M., and Koob G.F. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. Neuropsychopharmacology 33 3 (2008) 643-652
74. Walters C.L., Cleck J.N., Kuo Y.C., and Blendy J.A. Mu-opioid receptor and CREB activation are required for nicotine reward. Neuron 46 6 (2005) 933-943
75. Wang H., Cuzon V.C., and Pickel V.M. Postnatal development of mu-opioid receptors in the rat caudate-putamen nucleus parallels asymmetric synapse formation. Neuroscience 118 3 (2003) 695-708
76. Wang H., Cuzon V.C., and Pickel V.M. Ultrastructural localization of delta-opioid receptors in the rat caudate-putamen nucleus during postnatal development: relation to synaptogenesis. The Journal of Comparative Neurology 467 3 (2003) 343-353
77. White J.M. Pleasure into pain: the consequences of long-term opioid use. Addictive Behaviors 29 7 (2004) 1311-1324
78. White D.A., Michaels C.C., and Holtzman S.G. Periadolescent male but not female rats have higher motor activity in response to morphine than do adult rats. Pharmacology, Biochemistry, and Behavior 89 2 (2008) 188-199
79. Wilmouth C.E., and Spear L.P. Withdrawal from chronic nicotine in adolescent and adult rats. Pharmacology, Biochemistry, and Behavior 85 3 (2006) 648-657
80. Yukhananov R.Y.u., Zhai Q.Z., Persson S., Post C., and Nyberg F. Chronic administration of morphine decreases level of dynorphin A in the rat nucleus accumbens. Neuropharmacology 32 7 (1993) 703-709
81. Zhang L., Kendler K.S., and Chen X. The mu-opioid receptor gene and smoking initiation and nicotine dependence. Behavioral and Brain Functions 2 (2006) 28
82. Zheng X., Ke X., Tan B., Luo X., Xu W., Yang X., and Sui N. Susceptibility to morphine place conditioning: relationship with stress-induced locomotion and novelty-seeking behavior in juvenile and adult rats. Pharmacology, Biochemistry, and Behavior 75 4 (2003) 929-935
83. Zurita A., and Molina V. Prior morphine facilitates the occurrence of immobility and anhedonia following stress. Physiology and Behavior 65 4-5 (1999) 833-837